IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v7y2010i11p3929-3953d10127.html
   My bibliography  Save this article

Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead

Author

Listed:
  • Arun Kumar

    (Department of Civil Engineering, Indian Institute of Technology Delhi, Hauz Khas, New Delhi 110016, India)

  • Biao Chang

    (School of Civil and Environmental Engineering, Georgia Institute of Technology, 215 Sustainable Education Building, 788 Atlantic Drive NW, Atlanta, GA 30332, USA)

  • Irene Xagoraraki

    (Department of Civil and Environmental Engineering, A124 Engineering Research Complex, Michigan State University, East Lansing, MI 48824, USA)

Abstract

This study identified existing issues related to quantitative pharmaceutical risk assessment (QPhRA, hereafter) for pharmaceuticals in water and proposed possible solutions by analyzing methodologies and findings of different published QPhRA studies. Retrospective site-specific QPhRA studies from different parts of the world (U.S.A., United Kingdom, Europe, India, etc. ) were reviewed in a structured manner to understand different assumptions, outcomes obtained and issues, identified/addressed/raised by the different QPhRA studies. Till date, most of the published studies have concluded that there is no appreciable risk to human health during environmental exposures of pharmaceuticals; however, attention is still required to following identified issues: (1) Use of measured versus predicted pharmaceutical concentration, (2) Identification of pharmaceuticals-of-concern and compounds needing special considerations, (3) Use of source water versus finished drinking water-related exposure scenarios, (4) Selection of representative exposure routes, (5) Valuation of uncertainty factors, and (6) Risk assessment for mixture of chemicals. To close the existing data and methodology gaps, this study proposed possible ways to address and/or incorporation these considerations within the QPhRA framework; however, more research work is still required to address issues, such as incorporation of short-term to long-term extrapolation and mixture effects in the QPhRA framework. Specifically, this study proposed a development of a new “mixture effects-related uncertainty factor” for mixture of chemicals ( i.e. , mixUF composite ), similar to an uncertainty factor of a single chemical, within the QPhRA framework. In addition to all five traditionally used uncertainty factors, this uncertainty factor is also proposed to include concentration effects due to presence of different range of concentration levels of pharmaceuticals in a mixture. However, further work is required to determine values of all six uncertainty factors and incorporate them to use during estimation of point-of-departure values within the QPhRA framework.

Suggested Citation

  • Arun Kumar & Biao Chang & Irene Xagoraraki, 2010. "Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead," IJERPH, MDPI, vol. 7(11), pages 1-25, November.
  • Handle: RePEc:gam:jijerp:v:7:y:2010:i:11:p:3929-3953:d:10127
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/7/11/3929/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/7/11/3929/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Alberto A. López-Toro & Eva María Sánchez-Teba & María Dolores Benítez-Márquez & Mercedes Rodríguez-Fernández, 2021. "Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies," IJERPH, MDPI, vol. 18(9), pages 1-16, April.
    2. Sérgio Francisco de Aquino & Emanuel Manfred Freire Brandt & Sue Ellen Costa Bottrel & Fernanda Bento Rosa Gomes & Silvana de Queiroz Silva, 2021. "Occurrence of Pharmaceuticals and Endocrine Disrupting Compounds in Brazilian Water and the Risks They May Represent to Human Health," IJERPH, MDPI, vol. 18(22), pages 1-27, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:7:y:2010:i:11:p:3929-3953:d:10127. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.